Company news

Inoviq Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

IIQ signs EXO-OC validation agreement with Sonic Healthcare

November 1, 2026

IIQ signs EXO-OC validation agreement with Sonic Healthcare

November 1, 2026

Quarterly Activities Report and Appendix 4C - September 2026

October 28, 2026

Quarterly Activities Report and Appendix 4C - September 2026

October 28, 2026

INOVIQ Announces Leadership Change

October 22, 2026

EXO-OC Technical Review and Commercialisation Pathway

September 29, 2026

EXO-OC Study Outcome Investor Webinar Presentation

July 13, 2026

Quarterly Activities Report and Appendix 4C - June 2026

July 12, 2026

EXO-OC algorithm and clinical study update

June 30, 2026

Positive CAR-exosome data in ovarian cancer

June 24, 2026

Quarterly Activities Report and Appendix 4C - March 2026

April 27, 2026

Appendix 4D and FY26 Half Year Financial Report

February 17, 2026

Quarterly Business Update and Appendix 4C - December 2025

January 28, 2026

Positive in vivo CAR-EV data in TNBC

December 21, 2025

Quarterly Business Update and Appendix 4C - September 2025

October 28, 2025

IIQ completes placement and lodges SPP Offer Booklet

October 16, 2025

Investor Presentation

October 12, 2025

INOVIQ completes $9.5m placement

October 12, 2025

Trading Halt

October 8, 2025

IIQ Licences worldwide OC Biomarker IP from UniQuest

September 26, 2025

CAR-NK EVs kill Breast Cancer Cells in vitro at Peter Mac

September 22, 2025

Appendix 4E and Preliminary Financial Report

August 22, 2025

Quarterly Business Update and Appendix 4C - June 2025

July 30, 2025

INOVIQ Investor Webinar Presentation Slides

July 14, 2025

Response to ASX Query

June 23, 2025

New treatment kills 88% of Breast and Lung Cancer cells

June 17, 2025

Reinstatement to Official Quotation

June 2, 2025

Early Ovarian Cancer Screening Breakthrough

June 2, 2025

Suspension from Quotation

May 28, 2025

Response to ASX Price Query

May 27, 2025

Pause in Trade

May 26, 2025

Quarterly Business Update and Appendix 4C - March 2025

April 29, 2025

Appendix 4D and FY25 Half Year Financial Report

February 20, 2025

Quarterly Business Update and Appendix 4C - December 2024

January 30, 2025

Weaponising Exosomes for Breast Cancer treatment

December 15, 2024

Disease Specificity study completed for NeuCA15-3 test

December 4, 2024

EXO-OC test delivers outstanding performance

December 2, 2024

AGM CEO Presentation

November 27, 2024

INOVIQ receives $1m RDTI refund

November 25, 2024

Quarterly Business Update and Appendix 4C - September 2024

October 30, 2024

NEURO-NET validated in Parkinson's

August 19, 2024

Quarterly Activities Report and Appendix 4C - June 2024

July 29, 2024

Successful completion of Share Purchase Plan

July 4, 2024

INOVIQ lodges SPP and Options Prospectus

June 18, 2024

INOVIQ isolates brain-derived exosomes in Alzheimer's

June 12, 2024

INOVIQ completes $7m placement

June 12, 2024

Breakthrough Exosome Therapy

June 2, 2024

Quarterly Activities Report and Appendix 4C - March 2024

April 30, 2024

Ovarian Cancer Test Validation

April 18, 2024

INOVIQ Investor Update

April 17, 2024

Older news releases →

Decks

The 5 newest of 31 decks. Every deck is listed under its year.